Johnson & Johnson’s orthopedic sales rise 2.1% in Q2: 6 notes

Johnson & Johnson on July 17 posted increases in its orthopedic revenue during the second quarter of 2024.

Advertisement

Six things to know:

1. Second quarter orthopedic sales were $2.3 billion, up 2.1% year-over-year. 

2. Hip sales in the second quarter were $417 million, a 4.9% year-over-year increase. Knee sales rose 8.4% with $394 million. 

3. Quarterly spine, sports and other sales were $743 million, and trauma sales were $759 million.

4. The company reported total sales of $22.4 billion, a 4.3% increase year-over-year.

5. Johnson and Johnson’s net earnings in the second quarter were $4.7 billion, down from net earnings of $5.4 billion in the same period last year.

6. Operational sales for Johnson & Johnson MedTech grew 4.4%.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.